Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells

Experimental Cell Research

Volumn 244, Issue 1, 1998, Pages 157-170

  Gill, R Montgomery ^a   Slack, Ruth ^b   Kiess, Markus ^a   Hamel, Paul A ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c 6318 Medical Sciences Bldg ^*  (Canada)

Author keywords

Cell cycle; D cyclins; Differentiation; E2F; Kinase activity

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY;

ANIMALIA; MAMMALIA; MURINAE;

EID: 0032505753     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4197     Document Type: Article

References (87)

1. Vairo, G., Livingston, D. M., and Ginsberg, D. (1995). Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9, 869-881.
2. Helin, K., Harlow, E., and Fattaey, A. (1993). Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501-6508.
3. Ginsberg, D., et al. (1994). E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8, 2665-2679.
4. Zhu, L., et al. (1995). The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14, 1904-1913.
5. Goodrich, D. W., Wang, N. P., Qian, Y. W., Lee, E. Y., and Lee, W. H. (1991). The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67, 293-302.
6. Mayol, X., Garriga, J., and Grana, X. (1996). G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 13, 237-246.
7. Beijersbergen, R. L., Carlee, L., Kerkhoven, R. M., and Bernards, R. (1995). Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9, 1340-1353.
8. Chellappan, S. P., Hiebert, S., Mudryl, M., Horowitz, J. M., and Nevins, J. R. (1991). The E2F transcription factor is a cellular target for the RB protein. Cell 65, 1053-1061.
9. Sherr, C. J. (1993). Mammalian G1 cyclins. Cell 73, 1059-1065.
10. Sherr, C. J., and Roberts, J. M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
11. Helin, K., et al. (1992). A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 337-350.
12. Ivey-Hoyle, M., et al. (1993). Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13, 7802-7812.
13. Lees, J. A., et al. (1993). The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13, 7813-7825.
14. Sardet, C., et al. (1995). E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92, 2403-2407.
15. Hijmans, E. M., et al. (1995). E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 1555, 3082-3089.
16. Girling, R., et al. (1993). A new component of the transcription factor DRTF1/E2F. Nature 362, 83-87.
17. Wu, C.-L., Zukerberg, L. R., Ngwu, C., Harlow, E., and Lees, J. A. (1995). In vivo association of E2F and DP family proteins. Mol. Cell Biol. 15, 2536-2546.
18. Ormondroyd, E., de la Luna, S., and La Thangue, N. (1995). A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene 11, 1437-1446.
19. Krek, W., Livingston, D. M., and Shirodkar, S. (1993). Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262, 1557-1560.
20. Shan, B., and Lee, W. H. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173.
21. DeGregori, J., Leone, G., Ohtani, K., Miron, A., and Nevins, J. R. (1995). E2F-1 accumulation by passes a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9, 2873-2887.
22. Lukas, J., Petersen, B. O., Holm, K., Bartek, J., and Helin, K. (1996). Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16, 1047-1057.
23. Qin, X. Q., et al. (1995). The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15, 742-755.
24. Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins, J. R. (1993). Expression of transcription factor E2F1 induces quies cent cells to enter S phase. Nature 365, 349-352.
25. Dagnino, L., et al. (1997). Expression patterns of the E2F family of transcription factors during mouse nervous system development [In Process Citation]. Mech. Dev. 66, 13-25.
26. Dagnino, L., et al. (1997). Expression patterns of the E2F family of transcription factors during murine epithelial development. Cell Growth Differ. 8, 553-563.
27. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J. R. (1997). Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94, 7245-7250.
28. Hurford, R. K., Jr., Cobrinik, D., Lee, M. H., and Dyson, N. (1997). pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11, 1447-1463.
29. Dirks, P. B., Rutka, J. T., Hubbard, S. L., Mondal, S., and Hamel, P. A. (1998). The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells. Oncogene, in press.
30. Wang, J., Helin, K., Jin, P., and Nadal, G. B. (1995). Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ. 6, 1299-1306.
31. Reichel, R., Kovesdi, I., and Nevins, J. R. (1987). Developmental control of a promoter-specific factor that is also regulated by the E1A gene product. Cell 48, 501-506.
32. La Thangue, N. B., Thimmappaya, B., and Rigby, P. W. (1990). The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor. Nucleic Acids Res. 18, 2929-2938.
33. La Thangue, N. B., and Rigby, P. W. (1987). An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 49, 507-513.
34. Slack, R. S., et al. (1995). Cells differentiating into neuralectoderm undergo apoptosis in the absence of functional retinoblastoma family proteins. J. Cell Biol. 129, 779-788.
35. Bishopric, N. H., Zeng, G. Q., Sato, B., and Webster, K. A. (1997). Adenovirus E1A inhibits cardiac myocyte-specific gene expression through its amino terminus. J. Biol. Chem. 272, 20584-20594.
36. Caruso, M., Martelli, F., Giordano, A., and Felsani, A. (1993). Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8, 267-278.
37. Jiang, Z., Zacksenhaus, E., Gallie, B. L., and Phillips, R. A. (1997). The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14, 1789-1797.
38. Clarke, A. R., et al. (1992). Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330.
39. Jacks, T., et al. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
40. Lee, E. Y., et al. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
41. Zacksenhaus, E., et al. (1996). pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10, 3051-3064.
42. Lee, M.-H., et al. (1996). Targeted disruption of p107: functional overlap between p107 and RB. Genes Dev. 10, 1621-1632.
43. Aguzzi, A., Kiess, M., Rüedi, D., and Hamel, P. A. (1996). Cyclins D1, D2 and D3 are expressed in distinct tissues during mouse embryogenesis. Transgenics 2, 29-39.
44. Sicinski, P., et al. (1996). Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384, 470-474.
45. Sicinski, P., et al. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621-630.
46. Wang, J., and Walsh, K. (1996). Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex. Cell Growth Differ. 7, 1471-1478.
47. Rao, S. S., and Kohtz, D. S. (1995). Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270, 4093-4100.
48. Kiess, M., Gill, R. M., and Hamel, P. A. (1995). Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10, 159-166.
49. Rao, S. S., Chu, C., and Kohtz, D. S. (1994). Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14, 5259-5267.
50. Kato, J.-Y., and Sherr, C. J. (1993). Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA 90, 11513-11517.
51. Kranenburg, O., et al. (1996). Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15, 46-54.
52. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. (1995). Mice lacking cyclin D1 are small and shown defects in eye and mammary gland development. Genes Dev. 9, 2364-2372.
53. Kiyokawa, H., et al. (1996). Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721-732.
54. Missero, C., Di, C. F., Kiyokawa, H., Koff, A., and Dotto, G. P. (1996). The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10, 3065-3075.
55. Nakayama, K., et al. (1996). Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720.
56. Serrano, M., et al. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
57. Yan, Y., Frisen, J., Lee, M. H., Massague, J., and Barbacid, M. (1997). Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11, 973-983.
58. Wang, J., and Walsh, K. (1996). Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359-361.
59. Kranenburg, O., et al. (1995). Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J. Cell. Biol. 131, 227-234.
60. Poluha, W., et al. (1996). The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16, 1335-1341.
61. McBurney, M. W. (1993). P19 embryonal carcinoma cells. Int. J. Dev. Biol. 37, 135-140.
62. Rudnicki, M. A., and McBurney, M. W. (1988). In "Teratocarcinomas and Embryonic Stem Cells: A Practical Approach." (E. J. Robertson, Eds.) pp. 19-49, IRL Press, Oxford.
63. Yaffe, D. (1968). Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. USA 61, 477-483.
64. Schreiber, E., Matthias, P., Müller, M. M., and Schaffner, W. (1989). Rapid detection of octamer binding proteins with "mini extracts", prepared from a small number of cells. Nucleic Acid Res. 17, 6419.
65. Sleigh, M. J. (1986). A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells. Anal. Biochem. 156, 251-256.
66. Chomcynski, P., and Sacchi, N. (1987). Single step method of RNA isolation by acid guanidinium/thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
67. Reichel, R. R. (1992). Regulation of E2F/cyclin A-containing complex upon retinoic acid-induced differentiation of teratocarcinoma cells. Gene Expr. 2, 259-271.
68. Ikeda, M. A., Jakoi, L., and Nevins, J. R. (1996). A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93, 3215-3220.
69. Verona, R., et al. (1997). E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17, 7268-7282.
70. Lindeman, G. J., Gaubatz, S., Livingston, D. M., and Ginsberg, D. (1997). The subcellular localization of E2F-4 is cell-cycle dependent. Proc. Natl. Acad. Sci. USA 94, 5095-5100.
71. Shin, E. K., Shin, A., Paulding, C., Schaffhausen, B., and Yee, A. S. (1995). Multiple change in E2F function and regulation occur upon muscle differentiation. Mol. Cell. Biol. 15, 2252-2262.
72. LeCouter, J. E., Whyte, P. F., and Rudnicki, M. A. (1996). Cloning and expression of the Rb-related mouse p130 mRNA. Oncogene 12, 1433-1440.
73. Kiess, M., Gill, R. M., and Hamel, P. A. (1995). Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ. 6, 1287-1298.
74. Slack, R. S., Hamel, P. A., Bladon, T. S., Gill, R. M., and McBurney, M. W. (1993). Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene 8, 1585-1591.
75. Huber, H. E., Goodhart, P. J., and Huang, P. S. (1994). Retinoblastoma protein reverses DNA bending by transcription factor E2F. J. Biol. Chem. 269, 6999-7005.
76. Cress, W. D., and Nevins, J. R. (1996). A role for a bent DNA structure in E2F-mediated transcription activation. Mol. Cell. Biol. 16, 2119-2127.
77. Vlach, J., Hennecke, S., and Amati, B. (1997). Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27 [In Process Citation]. EMBO J. 16, 5334-5344.
78. LaBaer, J., et al. (1997). New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862.
79. Mummery, C. L., van Rooijen, M. A., van den Brink, S. E., and de Laat, S. W. (1987). Cell cycle analysis during retinoic acid induced differentiation of a human embryonal carcinoma-derived cell line. Cell Differ. 20, 153-160.
80. Corbeil, H. B., Whyte, P., and Branton, P. E. (1995). Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 11, 909-920.
81. Neuman, E., Flemington, E. K., Sellers, W. R., and Kaelin, W. G. (1994). Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14, 6607-615.
82. Johnson, D. G. (1995). Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11, 1685-1692.
83. Mudryj, M., et al. (1991). Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65, 1243-1253.
84. Font de Mora, J., Uren, A., Heidaran, M., and Santos, E. (1997). Biological activity of p27kip1 and its amino- and carboxy-terminal domains in G2/M transition of Xenopus oocytes [In Process Citation]. Oncogene 15, 2541-2551.
85. LaBaer, J., et al. (1997). New functional activities for the p21 family of CDK inhibitors [In Process Citation]. Genes Dev. 11, 847-862.
86. Polyak, K., et al. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
87. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78, 67-74.